Analytical Data
-
Gene name
sta1
- Application
-
Alternative Names
sta1；Signal transducer and activator of transcription 1-alpha/beta
-
Species
Human
-
Source
E. coli
-
Tag
GST tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P01559
-
Expression Region
55-72aa
-
AA Sequence
NTFYCCELCCNPACAGCY
-
Molecular Weight
28.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of STA1 recombinant protein has gained significant interest in recent years due to its potential applications in biotechnology and medicine. STA1, a protein encoded by the STA1 gene, plays a critical role in various cellular processes, including signal transduction and stress response. Understanding the structure and function of STA1 is essential for elucidating its biological roles and therapeutic potentials. In particular, researchers have focused on its impact on disease pathways, where alterations in STA1 expression have been linked to certain cancers and metabolic disorders. The recombinant production of STA1 allows for detailed investigation of its biochemical properties and interactions with other cellular components. Furthermore, the ability to produce large quantities of this protein in a controlled manner enables advancements in drug development, including the design of novel therapeutics that can modulate STA1-related pathways. Recent advances in protein expression systems and purification techniques have facilitated the characterization of STA1, revealing insights into its functional mechanisms. Overall, STA1 recombinant protein serves as a valuable tool for both scientific research and potential clinical applications, promoting a deeper understanding of its role in health and disease.
